Compensated pathogenic deviations
- PMID:25962036
- DOI: 10.1515/bmc.2011.025
Compensated pathogenic deviations
Abstract
Deleterious or 'disease-associated' mutations are mutations that lead to disease with high phenotype penetrance: they are inherited in a simple Mendelian manner, or, in the case of cancer, accumulate in somatic cells leading directly to disease. However, in some cases, the amino acid that is substituted resulting in disease is the wild-type native residue in the functionally equivalent protein in another species. Such examples are known as 'compensated pathogenic deviations' (CPDs) because, somewhere in the second species, there must be compensatory mutations that allow the protein to function normally despite having a residue which would cause disease in the first species. Depending on the nature of the mutations, compensation can occur in the same protein, or in a different protein with which it interacts. In principle, compensation can be achieved by a single mutation (most probably structurally close to the CPD), or by the cumulative effect of several mutations. Although it is clear that these effects occur in proteins, compensatory mutations are also important in RNA potentially having an impact on disease. As a much simpler molecule, RNA provides an interesting model for understanding mechanisms of compensatory effects, both by looking at naturally occurring RNA molecules and as a means of computational simulation. This review surveys the rather limited literature that has explored these effects. Understanding the nature of CPDs is important in understanding traversal along fitness landscape valleys in evolution. It could also have applications in treating diseases that result from such mutations.
Similar articles
- Intragenic compensation through the lens of deep mutational scanning.Azbukina N, Zharikova A, Ramensky V.Azbukina N, et al.Biophys Rev. 2022 Oct 26;14(5):1161-1182. doi: 10.1007/s12551-022-01005-w. eCollection 2022 Oct.Biophys Rev. 2022.PMID:36345285Free PMC article.Review.
- Compensated pathogenic deviations: analysis of structural effects.Baresić A, Hopcroft LE, Rogers HH, Hurst JM, Martin AC.Baresić A, et al.J Mol Biol. 2010 Feb 12;396(1):19-30. doi: 10.1016/j.jmb.2009.11.002. Epub 2009 Nov 6.J Mol Biol. 2010.PMID:19900462
- Characterization of compensated mutations in terms of structural and physico-chemical properties.Ferrer-Costa C, Orozco M, de la Cruz X.Ferrer-Costa C, et al.J Mol Biol. 2007 Jan 5;365(1):249-56. doi: 10.1016/j.jmb.2006.09.053. Epub 2006 Sep 26.J Mol Biol. 2007.PMID:17059831
- Dobzhansky-Muller incompatibilities in protein evolution.Kondrashov AS, Sunyaev S, Kondrashov FA.Kondrashov AS, et al.Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14878-83. doi: 10.1073/pnas.232565499. Epub 2002 Oct 28.Proc Natl Acad Sci U S A. 2002.PMID:12403824Free PMC article.
- Residue mutations and their impact on protein structure and function: detecting beneficial and pathogenic changes.Studer RA, Dessailly BH, Orengo CA.Studer RA, et al.Biochem J. 2013 Feb 1;449(3):581-94. doi: 10.1042/BJ20121221.Biochem J. 2013.PMID:23301657Review.
Cited by
- MitImpact 3: modeling the residue interaction network of the Respiratory Chain subunits.Castellana S, Biagini T, Petrizzelli F, Parca L, Panzironi N, Caputo V, Vescovi AL, Carella M, Mazza T.Castellana S, et al.Nucleic Acids Res. 2021 Jan 8;49(D1):D1282-D1288. doi: 10.1093/nar/gkaa1032.Nucleic Acids Res. 2021.PMID:33300029Free PMC article.
- Defective recognition of LC3B by mutant SQSTM1/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD.Goode A, Butler K, Long J, Cavey J, Scott D, Shaw B, Sollenberger J, Gell C, Johansen T, Oldham NJ, Searle MS, Layfield R.Goode A, et al.Autophagy. 2016 Jul 2;12(7):1094-104. doi: 10.1080/15548627.2016.1170257. Epub 2016 May 9.Autophagy. 2016.PMID:27158844Free PMC article.
- Intragenic compensation through the lens of deep mutational scanning.Azbukina N, Zharikova A, Ramensky V.Azbukina N, et al.Biophys Rev. 2022 Oct 26;14(5):1161-1182. doi: 10.1007/s12551-022-01005-w. eCollection 2022 Oct.Biophys Rev. 2022.PMID:36345285Free PMC article.Review.
- Enhancing missense variant pathogenicity prediction with protein language models using VariPred.Lin W, Wells J, Wang Z, Orengo C, Martin ACR.Lin W, et al.Sci Rep. 2024 Apr 7;14(1):8136. doi: 10.1038/s41598-024-51489-7.Sci Rep. 2024.PMID:38584172Free PMC article.
LinkOut - more resources
Full Text Sources
Research Materials